SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $20.00 per share, for total gross proceeds of approximately $100 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about January 12, 2016, subject to customary closing conditions. In addition, Otonomy has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at such offering price, less customary underwriting discounts and commissions. All of the common stock is being sold by Otonomy.
BofA Merrill Lynch, Cowen and Company and Piper Jaffray are acting as joint book-running managers for the offering. Sanford C. Bernstein and SunTrust Robinson Humphrey are acting as co-managers.
A shelf registration statement (File No. 333-206752) was previously filed with the Securities and Exchange Commission (SEC) on September 3, 2015 and became effective on September 14, 2015. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC on January 5, 2016. The final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. When available, copies of the final prospectus supplement and the accompanying prospectus relating to these securities may also be obtained by contacting one of the following: BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, or by email at [email protected]; Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department; or Piper Jaffray & Co., 800 Nicollet Mall, Suite 1000, Minneapolis, MN 55402, or by telephone at 800-747-3924, or by email at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Contacts: Media Inquiries Canale Communications Heidi Chokeir, Ph.D. Senior Vice President 619.849.5377 [email protected] Investor Inquiries Westwicke Partners Robert H. Uhl Managing Director 858.356.5932 [email protected]


LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 



